Veracyte Inc. Surpasses Analyst Target Price: What Comes Next?
In recent trading, shares of Veracyte Inc. (Symbol: VCYT) have crossed above the average analyst 12-month target price of $42.67, changing hands for $43.41/share. When a stock reaches an analyst’s target, there are typically two common responses: a downgrade based on valuation or an upward adjustment to the target price. Analyst reactions often hinge on the fundamental business developments that may be driving the stock price higher; if the company’s prospects seem positive, a higher target price might be warranted.
Diverse Analyst Opinions on VCYT’s Future
Among the 9 different analyst targets that contribute to the average for Veracyte Inc., there is a notable range in opinions. One analyst sets a price target as low as $28.00, while another has set a high target of $50.00. The standard deviation in these predictions is $6.91, highlighting the uncertainty among analysts.
Understanding the Wisdom of Crowds
Examining the average VCYT price target provides valuable insight, capturing the collective judgments of multiple analysts rather than the opinion of a single expert. With VCYT now surpassing the average target price of $42.67/share, investors may want to evaluate the situation: Could $42.67 be just a stepping stone toward an even higher target, or is it a signal that the stock has reached its valuation limit? Below is a table displaying the latest opinions from analysts covering Veracyte Inc.:
| Recent VCYT Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
| Strong buy ratings: | 7 | 8 | 7 | 5 |
| Buy ratings: | 1 | 1 | 1 | 1 |
| Hold ratings: | 2 | 1 | 1 | 1 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 1 | 1 | 1 | 1 |
| Average rating: | 1.75 | 1.57 | 1.63 | 1.79 |
The average rating in the table ranges from 1 to 5, where 1 indicates a Strong Buy and 5 represents a Strong Sell. This analysis utilized data provided by Zacks Investment Research via Quandl.com.
The Top 25 Broker Analyst Picks of the S&P 500 »
Also see:
10 Components Hedge Funds Are Selling
LKFN Insider Buying
Top Ten Hedge Funds Holding TYME
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
